BDBM316356 cis-2-[2-(3-Chlorophenyl)-6-[3-[ [(3S)-3-hydroxy-1-piperidyl]methyl]cyclobutyl]-4-oxo-quinazolin-3-yl]-N-isopropyl-acetamide::US9617226, Example 37

SMILES CC(C)NC(=O)Cn1c(nc2ccc(cc2c1=O)[C@@H]1C[C@H](CN2CCC[C@H](O)C2)C1)-c1cccc(Cl)c1

InChI Key InChIKey=ODFWFOVZOZZSHE-UHFFFAOYSA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 316356   

TargetVasopressin V1a receptor(Human)
Abbvie Deutschland

US Patent
LigandPNGBDBM316356( cis-2-[2-(3-Chlorophenyl)-6-[3-[ [(3S)-3-hydroxy-...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
Go to US Patent